Crossmark

Pathogenic connection between hypertension and type 2 diabetes: how do they mutually affect each other?

Published Online: 2022-09-13

Published Print: 2022-11

Authors

Tanaka, Atsushi

Node, Koichi
License Information

Text and Data Mining valid from 2022-09-13

Version of Record valid from 2022-09-13
More Information

Article History

Received: 27 July 2022

Accepted: 7 August 2022

First Online: 13 September 2022

Compliance with ethical standards

:

: AT has received honoraria from Boehringer Ingelheim and research funding from GlaxoSmithKline and Takeda. KN has received honoraria from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Kowa, Mitsubishi Tanabe, Mochida, MSD, Novartis, Novo Nordisk, Ono, Otsuka, and Teijin; research grants from Asahi Kasei, Astellas, Mitsubishi Tanabe, Teijin, Boehringer Ingelheim, Eli Lilly, Novartis, Fuji, and Mochida; and scholarships from Daiichi Sankyo Healthcare, Mitsubishi Tanabe, Teijin, Medtronic, and Bayer.

Free to read: This content has been made available to all.

Document is current